Skip To Main Content
Bruce Booth on Muck Rack

Bruce Booth

Cambridge
As seen in: BioPharma Dealmakers, Forbes, Nature, Airdrie & Coatbridge Advertiser, Kilmarnock Standard, Scottish Daily Record, Ayrshire Post, MedCity News, BioCentury, LifeSciVC
Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bruce

Contact Bruce, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Biotech Funding: Times Are Tough, Maybe For The Better - LifeSciVC

|
By Bruce Booth
| LifeSciVC
Times remain tough for private biotech venture capital funding. Access to capital is more constrained than it’s been in years, and companies are starting to feel the pinch. Yet, despite the pain after a cycle of excess, perhaps this return towards more discipline should be embraced. As has already been widely reported (here, here), aggregate venture capital funding in the first quarter of 2023 is well off its peaks of 2020-2022.
Open in Who Shared Issue with article?

This Too Shall Pass - LifeSciVC

|
By Bob Clarke, Bruce Booth
| LifeSciVC
By Robert Clarke, CEO of Kinaset, as part of the From The Trenches feature of LifeSciVC. Although I intend to shy away from the cult of celebrity, a recent clip from Tom Hanks resonated with me regarding the current state of the biotech market. As Mr Hanks continues his evolution into that trusted grandfatherly type of statesman, he spoke sagely with a group of peers and juniors reminding them all that “This too shall pass”.
Open in Who Shared Issue with article?

Hacking the Human Cell – How Once ‘Un-druggable’ Proteins Became the New Frontier in Drug Development - LifeSciVC

|
By Jonathan Montagu, Bruce Booth
| LifeSciVC
By Jonathan Montagu, CEO and founder of HotSpot Therapeutics, as part of the From The Trenches feature of LifeSciVC. White Hat Hackers, sometimes called “ethical hackers,” are individuals that work to find and fix security problems in a system by exploiting its entry points. They don’t use their computers like the rest of us do.
Open in Who Shared Issue with article?
See all 353 licensed articles (439 Total)